Hypertension device earns FDA breakthrough status

The latest stories trending on MedCity News.

Editor's Pick

Top Story Orchestra BioMed's Hypertension Device Wins FDA Breakthrough Designation Orchestra BioMed's hypertension treatment is the latest medical device to earn the FDA's breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers. Sponsored Changes in Nurse Staffing Answer Clinician Demands Presented by WhitePress The ongoing nursing shortage facilitates high turnover rates since nurses know they won't have difficulties finding new jobs. In order to retain and attract staff, it's in a facility's best interest to understand what nurses want. Learn More

Featured News

CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies Caribou Biosciences' restructuring narrows the biotech's focus to two off-the-shelf cell therapies for blood cancers, whose key data readouts have been pushed out to the second half of 2025. It's the CRISPR-editing company's second cash-saving restructuring in the past year. Agentic AI and the Architecture of Healthcare Transformation We need intelligent, scalable systems that lift burdens, illuminate connections, and empower healthcare professionals to deliver their highest-quality care. Agentic AI provides this essential capability. Community-Driven Digital Solutions Can Transform Addiction Treatment and Ease the Burden on the Healthcare System Technology has the power to revolutionize treatment, make it more widely available, provide additional patient insight, and ultimately, alleviate the strain on our already stressed healthcare system.

Video   What Should Employers Be Thinking About as They Develop Their Pharmacy Benefit Strategy? For Josh Golden, Capital Rx's senior vice president of strategy, it boils down to one question employers need to be asking themselves: Does my pharmacy benefit manager make more money when I spend more money? Most PBM profit models are tied directly to the price and volume of drugs, he noted.

Sponsored The Top 6 Best Analytics Tools for Health Care Revenue in 2025 Presented by Millennia Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources. Learn More

Resources

MedCity Pivot: What if Pancreatic Cancer Became a Chronic Disease? Ben Zeskind, co-founder, president and CEO of Immuneering, is attempting a new approach to treat certain types of cancers. If it works, there will be a vast improvement in the quality of life of cancer patients. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe